Cancer Stem Cells Market

Cancer Stem Cells Market: Snapshot

The rising shift in oncology therapeutics from conventional therapies such as surgeries, chemotherapy, and radiotherapy to stem cell therapies points at expansive growth cancer stem cells market over the 2020 – 2030 forecast period.

Over the past couple of years, stem cells have found valuable use for replacement of blood after tumor formation or after tumor treatment. In addition, stem cell research has the capability to manufacture different types of medicines for diseases along with discovering drugs that can be used for the treatment of cancer.

Cancer Stem Cells Market: Notable Development and Competitive Landscape

In a recent development, researchers at Tel Aviv University introduced advanced biosensor that can target leukemic cells. The researchers are focused on to decrease the rate of relapse of blood cancer by targeting the most malignant leukemic stem cells. Meanwhile, stem cell research is a rapidly developing medical area in Turkey, now recognized as the ‘rising star of Europe in stem cell’.

Prominent players operating in the cancer stem cells market are AdnaGen GmbH, Epic Sciences Inc., AVIVA Biosciences Corporation, Advanced Cell Diagnostics Inc., Rarecells USA Inc., Fluxion Biosciences Inc., Celula Inc., and Silicon Biosystems S.p.A.

Cancer Stem Cells Market: Key Trends

Rapid adoption of stem cells by healthcare professionals for tissue regeneration and as tools for delivery of anti-cancer agents is spurring growth of cancer stem cells market. Healthcare professionals world over report positive outcome of using stem cells for treatment of tumor.

However, on the downside, high cost of stem cell therapy treatment and strict regulations of international healthcare agencies for the use of stem cell therapy are hindering the growth of cancer stem cells market.

Cancer Stem Cells Market: Regional Outlook

North America cancer stem cells market is estimated to expand at a notable growth rate in the years ahead. Advances in medical research and availability of state-of-the-art infrastructure for medical research are contributing to the growth of cancer stem cells market in the region.